We report the results of a retrospective analysis in 27 pediatric patients who received low-dose MTX as the second-line treatment for steroid-refractory or -dependent acute and chronic GVHD. Between ...
As a cytotoxic and immunosuppressive drug, MTX has been successfully used for the prevention of aGVHD. Our recently published data 9 showed that low doses of MTX can be used as a second-line option to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results